Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis

We determined the specific lymphocyte proliferative response and cytokine profile production regarding Toxoplasma P30 (2017 from virulent and non-virulent strain) and ROP18 protein-derived peptides (from clonal lineages I, II and III) in 19 patients having ocular toxoplasmosis, five suffering chroni...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2014
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22571
Acceso en línea:
https://doi.org/10.1007/s00430-014-0339-0
https://repository.urosario.edu.co/handle/10336/22571
Palabra clave:
CD3 antigen
CD4 antigen
CD8 antigen
Gamma interferon
Interleukin 10
Protein p30
ROP18 protein
Tumor necrosis factor alpha
Unclassified drug
Virulence factor
Cytokine
Leukocyte antigen
Parasite antigen
Protein serine threonine kinase
Protozoal protein
Adult
Antigen specificity
Article
Asymptomatic disease
Carboxy terminal sequence
CD4+ T lymphocyte
CD8+ T lymphocyte
Child
Clinical article
Controlled study
Cytokine production
Ex vivo study
Female
Human
Human cell
Immune response
Immunostimulation
Male
Nonhuman
Parasite virulence
Th1 cell
Th2 cell
Toxoplasmosis
Adolescent
Cell proliferation
Chemistry
Flow cytometry
Immunology
Middle aged
Mononuclear cell
Secretion (process)
T lymphocyte subpopulation
Th1 cell
Th2 cell
Toxoplasmosis
Young adult
Adolescent
Adult
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Proliferation
Child
Cytokines
Female
Flow Cytometry
Humans
Male
Middle Aged
Protein-Serine-Threonine Kinases
Protozoan Proteins
T-Lymphocyte Subsets
Th1 Cells
Th2 Cells
Toxoplasmosis
Young Adult
IL10
Interferon gamma
P30 protein
Peptides
ROP18
Th1
Th2
Toxoplasma
Vaccine
Protozoan
Toxoplasma
CD
Mononuclear
Toxoplasma gondii
ROP18 protein
SAG1 antigen
Antigens
Antigens
Leukocytes
Rights
License
Abierto (Texto Completo)
id EDOCUR2_16fc8a0287b1bb8f8fd7e510df68af1e
oai_identifier_str oai:repository.urosario.edu.co:10336/22571
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
dc.title.spa.fl_str_mv Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
title Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
spellingShingle Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
CD3 antigen
CD4 antigen
CD8 antigen
Gamma interferon
Interleukin 10
Protein p30
ROP18 protein
Tumor necrosis factor alpha
Unclassified drug
Virulence factor
Cytokine
Leukocyte antigen
Parasite antigen
Protein serine threonine kinase
Protozoal protein
Adult
Antigen specificity
Article
Asymptomatic disease
Carboxy terminal sequence
CD4+ T lymphocyte
CD8+ T lymphocyte
Child
Clinical article
Controlled study
Cytokine production
Ex vivo study
Female
Human
Human cell
Immune response
Immunostimulation
Male
Nonhuman
Parasite virulence
Th1 cell
Th2 cell
Toxoplasmosis
Adolescent
Cell proliferation
Chemistry
Flow cytometry
Immunology
Middle aged
Mononuclear cell
Secretion (process)
T lymphocyte subpopulation
Th1 cell
Th2 cell
Toxoplasmosis
Young adult
Adolescent
Adult
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Proliferation
Child
Cytokines
Female
Flow Cytometry
Humans
Male
Middle Aged
Protein-Serine-Threonine Kinases
Protozoan Proteins
T-Lymphocyte Subsets
Th1 Cells
Th2 Cells
Toxoplasmosis
Young Adult
IL10
Interferon gamma
P30 protein
Peptides
ROP18
Th1
Th2
Toxoplasma
Vaccine
Protozoan
Toxoplasma
CD
Mononuclear
Toxoplasma gondii
ROP18 protein
SAG1 antigen
Antigens
Antigens
Leukocytes
title_short Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
title_full Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
title_fullStr Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
title_full_unstemmed Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
title_sort Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis
dc.subject.keyword.spa.fl_str_mv CD3 antigen
CD4 antigen
CD8 antigen
Gamma interferon
Interleukin 10
Protein p30
ROP18 protein
Tumor necrosis factor alpha
Unclassified drug
Virulence factor
Cytokine
Leukocyte antigen
Parasite antigen
Protein serine threonine kinase
Protozoal protein
Adult
Antigen specificity
Article
Asymptomatic disease
Carboxy terminal sequence
CD4+ T lymphocyte
CD8+ T lymphocyte
Child
Clinical article
Controlled study
Cytokine production
Ex vivo study
Female
Human
Human cell
Immune response
Immunostimulation
Male
Nonhuman
Parasite virulence
Th1 cell
Th2 cell
Toxoplasmosis
Adolescent
Cell proliferation
Chemistry
Flow cytometry
Immunology
Middle aged
Mononuclear cell
Secretion (process)
T lymphocyte subpopulation
Th1 cell
Th2 cell
Toxoplasmosis
Young adult
Adolescent
Adult
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Proliferation
Child
Cytokines
Female
Flow Cytometry
Humans
Male
Middle Aged
Protein-Serine-Threonine Kinases
Protozoan Proteins
T-Lymphocyte Subsets
Th1 Cells
Th2 Cells
Toxoplasmosis
Young Adult
IL10
Interferon gamma
P30 protein
Peptides
ROP18
Th1
Th2
Toxoplasma
Vaccine
topic CD3 antigen
CD4 antigen
CD8 antigen
Gamma interferon
Interleukin 10
Protein p30
ROP18 protein
Tumor necrosis factor alpha
Unclassified drug
Virulence factor
Cytokine
Leukocyte antigen
Parasite antigen
Protein serine threonine kinase
Protozoal protein
Adult
Antigen specificity
Article
Asymptomatic disease
Carboxy terminal sequence
CD4+ T lymphocyte
CD8+ T lymphocyte
Child
Clinical article
Controlled study
Cytokine production
Ex vivo study
Female
Human
Human cell
Immune response
Immunostimulation
Male
Nonhuman
Parasite virulence
Th1 cell
Th2 cell
Toxoplasmosis
Adolescent
Cell proliferation
Chemistry
Flow cytometry
Immunology
Middle aged
Mononuclear cell
Secretion (process)
T lymphocyte subpopulation
Th1 cell
Th2 cell
Toxoplasmosis
Young adult
Adolescent
Adult
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Proliferation
Child
Cytokines
Female
Flow Cytometry
Humans
Male
Middle Aged
Protein-Serine-Threonine Kinases
Protozoan Proteins
T-Lymphocyte Subsets
Th1 Cells
Th2 Cells
Toxoplasmosis
Young Adult
IL10
Interferon gamma
P30 protein
Peptides
ROP18
Th1
Th2
Toxoplasma
Vaccine
Protozoan
Toxoplasma
CD
Mononuclear
Toxoplasma gondii
ROP18 protein
SAG1 antigen
Antigens
Antigens
Leukocytes
dc.subject.keyword.eng.fl_str_mv Protozoan
Toxoplasma
CD
Mononuclear
Toxoplasma gondii
ROP18 protein
SAG1 antigen
Antigens
Antigens
Leukocytes
description We determined the specific lymphocyte proliferative response and cytokine profile production regarding Toxoplasma P30 (2017 from virulent and non-virulent strain) and ROP18 protein-derived peptides (from clonal lineages I, II and III) in 19 patients having ocular toxoplasmosis, five suffering chronic asymptomatic infection, nine with congenital toxoplasmosis and eight Toxoplasma negative people. A Beckman Coulter FC500 flow cytometer was used for determining antigen-specific T cells (CD3+ CD4+ or CD3+ CD8+ cells) in peripheral blood culture. IFN ? and IL10 levels were determined in culture supernatants. Specific CD4+ and CD8+ T cell response to total antigen and P30- and ROP18-derived peptides was observed in infected people. Ocular toxoplasmosis patients had a preferential Th2 response after antigenic stimulation. Non-virulent peptide 2017 was able to shift response toward Th1 in congenitally infected children and virulent peptide 2017 induced a Th2 response in chronically infected, asymptomatic people. An immune response in human toxoplasmosis after ex vivo antigenic stimulation was Th1- or Th2-skewed, depending on a patient’s clinical condition. Colombian ocular toxoplasmosis patients’ immune response was Th2-skewed, regardless of the nature of antigen stimulus. © 2014, Springer-Verlag Berlin Heidelberg.
publishDate 2014
dc.date.created.spa.fl_str_mv 2014
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:56:57Z
dc.date.available.none.fl_str_mv 2020-05-25T23:56:57Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1007/s00430-014-0339-0
dc.identifier.issn.none.fl_str_mv 14321831
03008584
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22571
url https://doi.org/10.1007/s00430-014-0339-0
https://repository.urosario.edu.co/handle/10336/22571
identifier_str_mv 14321831
03008584
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 322
dc.relation.citationIssue.none.fl_str_mv No. 5
dc.relation.citationStartPage.none.fl_str_mv 315
dc.relation.citationTitle.none.fl_str_mv Medical Microbiology and Immunology
dc.relation.citationVolume.none.fl_str_mv Vol. 203
dc.relation.ispartof.spa.fl_str_mv Medical Microbiology and Immunology, ISSN:14321831, 03008584, Vol.203, No.5 (2014); pp. 315-322
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-84919477257&doi=10.1007%2fs00430-014-0339-0&partnerID=40&md5=4b6c72c20def77684d4ff6b2fb732f31
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Springer Verlag
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/0946f903-8b90-410e-87ef-691733a2348c/download
https://repository.urosario.edu.co/bitstreams/f80718fe-9a68-402f-8d5b-0ed15674c3b3/download
https://repository.urosario.edu.co/bitstreams/19cdf233-d9a5-49c8-9d21-da20fb538855/download
bitstream.checksum.fl_str_mv aaf9e647a355ed43f23d9c9ef6b24ce7
8297aa213d3c9896a1c0c823da1d0693
fa608c1f61adf035dbf072e3504a40d1
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167574930259968
spelling a92dd30e-6b14-475b-9019-af4ecb1e37b201cb24af-9e52-4530-b0ba-58c1ad4dbc2beae864ff-3bb7-4d21-bb67-fa279d73a7fe5170135560070bb29e3-42d1-4e74-99fd-de83a3c415458f776c1e-0499-4177-84fc-562088cd14a8796530656002020-05-25T23:56:57Z2020-05-25T23:56:57Z2014We determined the specific lymphocyte proliferative response and cytokine profile production regarding Toxoplasma P30 (2017 from virulent and non-virulent strain) and ROP18 protein-derived peptides (from clonal lineages I, II and III) in 19 patients having ocular toxoplasmosis, five suffering chronic asymptomatic infection, nine with congenital toxoplasmosis and eight Toxoplasma negative people. A Beckman Coulter FC500 flow cytometer was used for determining antigen-specific T cells (CD3+ CD4+ or CD3+ CD8+ cells) in peripheral blood culture. IFN ? and IL10 levels were determined in culture supernatants. Specific CD4+ and CD8+ T cell response to total antigen and P30- and ROP18-derived peptides was observed in infected people. Ocular toxoplasmosis patients had a preferential Th2 response after antigenic stimulation. Non-virulent peptide 2017 was able to shift response toward Th1 in congenitally infected children and virulent peptide 2017 induced a Th2 response in chronically infected, asymptomatic people. An immune response in human toxoplasmosis after ex vivo antigenic stimulation was Th1- or Th2-skewed, depending on a patient’s clinical condition. Colombian ocular toxoplasmosis patients’ immune response was Th2-skewed, regardless of the nature of antigen stimulus. © 2014, Springer-Verlag Berlin Heidelberg.application/pdfhttps://doi.org/10.1007/s00430-014-0339-01432183103008584https://repository.urosario.edu.co/handle/10336/22571engSpringer Verlag322No. 5315Medical Microbiology and ImmunologyVol. 203Medical Microbiology and Immunology, ISSN:14321831, 03008584, Vol.203, No.5 (2014); pp. 315-322https://www.scopus.com/inward/record.uri?eid=2-s2.0-84919477257&doi=10.1007%2fs00430-014-0339-0&partnerID=40&md5=4b6c72c20def77684d4ff6b2fb732f31Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCD3 antigenCD4 antigenCD8 antigenGamma interferonInterleukin 10Protein p30ROP18 proteinTumor necrosis factor alphaUnclassified drugVirulence factorCytokineLeukocyte antigenParasite antigenProtein serine threonine kinaseProtozoal proteinAdultAntigen specificityArticleAsymptomatic diseaseCarboxy terminal sequenceCD4+ T lymphocyteCD8+ T lymphocyteChildClinical articleControlled studyCytokine productionEx vivo studyFemaleHumanHuman cellImmune responseImmunostimulationMaleNonhumanParasite virulenceTh1 cellTh2 cellToxoplasmosisAdolescentCell proliferationChemistryFlow cytometryImmunologyMiddle agedMononuclear cellSecretion (process)T lymphocyte subpopulationTh1 cellTh2 cellToxoplasmosisYoung adultAdolescentAdultCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell ProliferationChildCytokinesFemaleFlow CytometryHumansMaleMiddle AgedProtein-Serine-Threonine KinasesProtozoan ProteinsT-Lymphocyte SubsetsTh1 CellsTh2 CellsToxoplasmosisYoung AdultIL10Interferon gammaP30 proteinPeptidesROP18Th1Th2ToxoplasmaVaccineProtozoanToxoplasmaCDMononuclearToxoplasma gondiiROP18 proteinSAG1 antigenAntigensAntigensLeukocytesTh1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosisarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Torres-Morales, ElizabethTaborda, LauraCardona, Nestorde-la-Torre, AlejandraSepulveda-Arias, Juan CarlosGomez-Marin, Jorge EnriquePatarroyo, Manuel A.ORIGINALTorres-Morales2014_Article_Th1AndTh2ImmuneResponseToP30An.pdfapplication/pdf692848https://repository.urosario.edu.co/bitstreams/0946f903-8b90-410e-87ef-691733a2348c/downloadaaf9e647a355ed43f23d9c9ef6b24ce7MD51TEXTTorres-Morales2014_Article_Th1AndTh2ImmuneResponseToP30An.pdf.txtTorres-Morales2014_Article_Th1AndTh2ImmuneResponseToP30An.pdf.txtExtracted texttext/plain31621https://repository.urosario.edu.co/bitstreams/f80718fe-9a68-402f-8d5b-0ed15674c3b3/download8297aa213d3c9896a1c0c823da1d0693MD52THUMBNAILTorres-Morales2014_Article_Th1AndTh2ImmuneResponseToP30An.pdf.jpgTorres-Morales2014_Article_Th1AndTh2ImmuneResponseToP30An.pdf.jpgGenerated Thumbnailimage/jpeg4659https://repository.urosario.edu.co/bitstreams/19cdf233-d9a5-49c8-9d21-da20fb538855/downloadfa608c1f61adf035dbf072e3504a40d1MD5310336/22571oai:repository.urosario.edu.co:10336/225712022-05-02 07:37:15.941733https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co